Page last updated: 2024-11-02

oxotremorine and Cardiomegaly

oxotremorine has been researched along with Cardiomegaly in 1 studies

Oxotremorine: A non-hydrolyzed muscarinic agonist used as a research tool.

Cardiomegaly: Enlargement of the HEART, usually indicated by a cardiothoracic ratio above 0.50. Heart enlargement may involve the right, the left, or both HEART VENTRICLES or HEART ATRIA. Cardiomegaly is a nonspecific symptom seen in patients with chronic systolic heart failure (HEART FAILURE) or several forms of CARDIOMYOPATHIES.

Research Excerpts

ExcerptRelevanceReference
"2."1.29Reduced muscarinic cholinoceptor density and sensitivity in various models of experimental cardiac hypertrophy. ( Batink, HD; Mathy, MJ; Mertens, MJ; Pfaffendorf, M; van Zwieten, PA, 1995)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mertens, MJ1
Batink, HD1
Mathy, MJ1
Pfaffendorf, M1
van Zwieten, PA1

Other Studies

1 other study available for oxotremorine and Cardiomegaly

ArticleYear
Reduced muscarinic cholinoceptor density and sensitivity in various models of experimental cardiac hypertrophy.
    Journal of autonomic pharmacology, 1995, Volume: 15, Issue:6

    Topics: Animals; Cardiomegaly; Heart; Hemodynamics; In Vitro Techniques; Male; Methacholine Chloride; Muscar

1995